Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy”: Annals of Oncology 2020; 31, suppl.4: S472 (abstr. 540P) | ANNALS OF ONCOLOGY |